Blaž Koritnik

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Benedikt Schoser, Mark Roberts, Barry J. Byrne et al. · The Lancet Neurology · 2021 · 124 citations

Clinical Trials, Cipaglucosidase Alfa, Pharmacotherapy +2

New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

Jorge Alonso‐Pérez, Lidia González‐Quereda, Luca Bello et al. · Brain · 2020 · 74 citations · Full text

Genetic Epidemiology, Human Polymorphism, Pathology +29

Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls

Anja Kovanda, Lea Leonardis, Janez Zidar et al. · Scientific Reports · 2018 · 69 citations · Full text

Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis

Ana Dolinar, Blaž Koritnik, Damjan Glavač et al. · Molecular Neurobiology · 2019 · 66 citations · Full text

Imaging the brain during sniffing: A pilot fMRI study

Blaž Koritnik, Sheba Azam, Chris Andrew et al. · Pulmonary Pharmacology & Therapeutics · 2008 · 63 citations · Full text

Neuroimaging Modality, Brain Function, Medicine +9